goof ball Julius Caesar’ Actor on Trump-Stabbing Play:

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone john1234 #23765
233
goof ball Julius Caesar’ Actor on Trump-Stabbing Play: ‘This Is Resistance’



Actor Corey Stoll has opened up about his experience
starring in the Public Theater’s controversial staging of Julius Caesar this summer, explaining that performing the play in the wake of protests and criticism was itself a form of “resistance.”

In an essay for Vulture, the 41-year-old House of Cards star, who played Marcus Brutus in the play, wrote that he initially did not know the Caesar character would be a stand-in for President Donald Trump, complete with blonde hair and business suit. The character’s resemblance to the president sparked outrage when, as happens in the Shakespeare classic, the Trump-like Caesar is brutally stabbed to death by his associates in the Senate. The controversy led two sponsors of the Public Theater, Delta Air Lines and Bank of America, to pull their funding, while hecklers interrupted the performance during its final few nights.

“The protesters never shut us down, but we had to fight each night to make sure they did not distort the story we were telling,” Stoll wrote. “At that moment, watching my castmates hold their performances together, it occurred to me that this is resistance.”

The actor wrote that he initially disapproved of the Caesar character’s resemblance to Trump, though he had “little fear of offending people” and did not believe anyone would view the play as an “endorsement of violence” against the president.

“Absorbed in our previews, I was unaware that we had become a target of right-wing attacks,” he wrote. “In a company meeting the Friday before our opening night, we were told that some conservative websites claimed to be outraged by the production. Threats had been made. Security was being increased. I raised my hand and asked what we should do if someone tried to stop the show. Some of my castmates laughed. Brutus was making me paranoid.”

Stoll added that by the time of the final performance of the play on June 18, he had become “exhausted and nervous” due to repeated interruptions by hecklers and others audience members who rushed the stage during the assassination scene.

“In this new world where art is willfully misinterpreted to score points and to distract, simply doing the work of an artist has become a political act,” he concluded. “I’m thankful for all the beautiful defenses of our production written in the last few weeks. But the cliché is true: In politics, when you’re explaining, you’re losing. So if you’re making art, by all means question yourself and allow yourself to be influenced by critics of good faith. But don’t allow yourself to be gaslighted or sucked into a bad-faith argument.”

The Public Theater defended its production after the initial backlash, acknowledging in a statement that the play had provoked “heated discussion” but that “such discussion is exactly the goal of our civically-engaged theater; this discourse is the basis of a healthy democracy.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 128

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Tenax Therapeutics Faces Class Action Amid Massive Loss

Updated Category News Views 188

Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...

Continue Reading
Nicely Network: Top Reddit Marketing for Big Brands

Updated Category News Views 166

Reddit and AI: Nicely Network's Winning Formula Straight out of New York comes the latest scoop: Nicely Network's been crowned king of the Reddit jungle, earning the title of Best Reddit Marketing Agency for Enterprise Brands this November, courtesy of Better Business Advice. Now, if you've been paying any attention to how brands are grappling with the impossible search...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 17

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading
Virtual K-Pop Takes U.S. by Storm: HYPEVERSE Emerges

Updated Category News Views 194

The Rise of Virtual K-Pop Across the Atlantic It's a bold new world for K-pop, and HYPEVERSE is leading the charge. Forget the typical idol group—this one's pulling out all the stops by going virtual and zeroing in on American audiences. Now, as someone who's been burned by the volatility of music stocks in the past, I'm peering at this development with a mix of...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 191

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 173

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 92

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 273

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
XPeng Hits New Monthly Delivery Record in October

Updated Category News Views 304

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

Continue Reading

Top 5 Most Recently Viewed Articles

Cumberland Pharmaceuticals Plans Q3 2024 Financial Update Soon

Updated Category News Views 119

Cumberland Pharmaceuticals Set to Announce Q3 2024 Results Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, is gearing up to disclose its financial performance for the third quarter of 2024. This event will take place following the market's closure on a designated Thursday in November, allowing stakeholders to gain insight into the...

Continue Reading
Halliburton's Q2 Performance: CEO Warns of Market Challenges

Updated Category News Views 156

Halliburton's Recent Performance Overview Halliburton Co. (NYSE: HAL) recently reported second-quarter earnings that surpassed revenue estimates while aligning with earnings expectations. Despite this promising financial report, shares traded lower, reflecting concerns stemming from CEO Jeff Miller's cautious outlook regarding the short-term oilfield services market....

Continue Reading
Urgent Need for Debt Ceiling Action as Government Funds Dwindle

Updated Category News Views 396

Urgent Need for Debt Ceiling Action The United States is at a critical juncture as Treasury Secretary Janet L. Yellen has stated that the government has less than three weeks to address its debt limit. Her announcement emphasizes the urgency of Congressional intervention. The Implications of Not Raising the Debt Limit Yellen conveyed her concerns through a letter to...

Continue Reading
Scenthound Highlights Importance of Pet Dental Care Month

Updated Category News Views 130

Scenthound Highlights Importance of Pet Dental Care Month Nation's Leading Dog Wellness Franchise Champions Pet Health through Education, Services, and Innovative Products As we dive into the dedicated celebration of Pet Dental Health Month, Scenthound is at the forefront of emphasizing the essential role dental hygiene plays in the health of dogs. The franchise aims to...

Continue Reading
Charles Cynamon's Leadership Role at Telesat Government Solutions

Updated Category News Views 119

Charles Cynamon Takes the Helm at Telesat Government Solutions OTTAWA, Ontario and ARLINGTON, Va. – Telesat (NASDAQ and TSX: TSAT), a prominent player in the satellite industry, has appointed Charles "Chuck" Cynamon as President of Telesat Government Solutions. This division, dedicated to providing secure satellite solutions for U.S. Government civil, military, and...

Continue Reading